You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
Baxter

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

GALLIUM CITRATE GA 67 Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Gallium Citrate Ga 67, and when can generic versions of Gallium Citrate Ga 67 launch?

Gallium Citrate Ga 67 is a drug marketed by Curium, Ge Healthcare, and Lantheus Medcl. and is included in three NDAs.

The generic ingredient in GALLIUM CITRATE GA 67 is gallium citrate ga-67. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gallium citrate ga-67 profile page.

Summary for GALLIUM CITRATE GA 67
Drug patent expirations by year for GALLIUM CITRATE GA 67
Recent Clinical Trials for GALLIUM CITRATE GA 67

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Aridis Pharmaceuticals, Inc.Phase 1/Phase 2
Radiological Society of North AmericaPhase 2
Rutgers, The State University of New JerseyPhase 2

See all GALLIUM CITRATE GA 67 clinical trials

US Patents and Regulatory Information for GALLIUM CITRATE GA 67

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Curium GALLIUM CITRATE GA 67 gallium citrate ga-67 INJECTABLE;INJECTION 018058-001 Approved Prior to Jan 1, 1982 BS RX No No   Start Trial   Start Trial   Start Trial
Ge Healthcare GALLIUM CITRATE GA 67 gallium citrate ga-67 INJECTABLE;INJECTION 017700-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Lantheus Medcl GALLIUM CITRATE GA 67 gallium citrate ga-67 INJECTABLE;INJECTION 017478-001 Approved Prior to Jan 1, 1982 BS RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Moodys
Colorcon
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.